Intensity-Modulated Fractionated Radiotherapy Versus Stereotactic Body Radiotherapy for Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Intensity-Modulated Fractionated Radiotherapy Versus Stereotactic Body Radiotherapy for Prostate Cancer (PACE-B): Acute Toxicity Findings From An International, Randomised, Open-Label, Phase 3, Non-Inferiority Trial
Lancet Oncol 2019 Sep 17;[EPub Ahead of Print], DH Brand, AC Tree, P Ostler, H van der Voet, A Loblaw, W Chu, D Ford, S Tolan, S Jain, A Martin, J Staffurth, P Camilleri, K Kancherla, J Frew, A Chan, IS Dayes, D Henderson, S Brown, C Cruickshank, S Burnett, A Duffton, C Griffin, V Hinder, K Morrison, O Naismith, E Hall, N van AsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.